ONCONETIX

Pharmaceutical preparations for the treatment of cancer featuring small molecules, biopharmaceuticals, Antibody-Drug-Conjugates (ADCs), Oncolytic viruses, virus-like particles-based therapeutics, and nano-encapsulated drug like synthetic therapeutics; Pharmaceutical preparations for the treatment of cancer for use in cellular therapies, gene therapies, N - 1 personalized drug therapies, and CAR T-cell therapy; Pharmaceutical preparations for the treatment of cancer derived from CRISPR-Cas9 and CAR T-Cell; Vaccine preparations; Antibodies for medical purposes, namely, monoclonal antibodies and bi-specific antibodies; Medical diagnostic reagents and diagnostic preparations for use in-vitro, in-vivo, cell-based assays, cell culture processes, laboratory-developed tests (LDTs), cell-based imagining, genomics, gene-based expression assays, proteomics, protein-based expression assays, immunohistochemistry (IHC), drug sensitivity and treatment diagnostics

Downloadable medical computer software platforms containing diagnostic algorithms and decision-making computation to support screening, diagnosing, monitoring and treatment modalities of diseases; downloadable medical computer software platforms for aiding in decision-making in clinical and after-regulatory approval of therapeutics and diagnostics; downloadable medical computer software platforms for managing and maintaining pre-clinical trials, clinical trials and assessments of patient's tumors in their staging and treatment

Medical apparatus for personalized medical therapeutics, namely, infusion and injection devices for administering therapeutic drugs of various types, namely, small molecules, biopharmaceuticals, cellular therapies, gene therapies, vaccines, CRISPR-Cas9 derived, CAR T-Cell derived, N - 1 personalized drug therapies, Antibody-Drug-Conjugates (ADCs), Oncolytic viruses, monoclonal antibodies, bi-specific antibodies, virus-like particles-based therapeutics, and nano-encapsulated drug like synthetic therapeutics, into the human body utilizing both in-vivo and in-vitro, gene or cellular therapy methods

Medical research services in personalized medicine, patient treatment, therapeutics and diagnostics

Biobanking services, namely, human and animal organ and tissue bank services; Medical digital pathology services for diagnostic or treatment purposes of human and animal tumors; Medical imaging services for cellular systems for the characterization of human and animal tumors